SCHEMBL20208271

SCHEMBL20208271

COC(=O)CC[C@@H](C)C1CCC2C3C(CC[C@@]21C)[C@@]1(C)CCCC[C@H]1C[C@H]3O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 10/20 0.80
▸ NR1H4 Q96RI1 4/20 0.80
▸ CYP2C9 P11712 1/20 0.66
▸ HIF1A Q16665 1/20 0.66
▸ VDR P11473 1/20 0.66
▸ CYP3A4 P08684 3/20 0.64
▸ MEN1 O00255 3/20 0.64
▸ KMT2A Q03164 3/20 0.64
▸ SLCO1B3 Q9NPD5 1/20 0.64
▸ SLCO1B1 Q9Y6L6 1/20 0.64
▸ USP2 O75604 1/20 0.64
▸ ABCB11 O95342 2/20 0.63
▸ SLC10A2 Q12908 2/20 0.63
▸ LMNA P02545 1/20 0.63
▸ CYP2C19 P33261 1/20 0.63
▸ CHRM2 P08172 1/20 0.63
▸ ADRA2A P08913 1/20 0.63
▸ ADRA1A P35348 1/20 0.63
▸ TDP1 Q9NUW8 1/20 0.63
▸ ENPP2 Q13822 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23483145 1.00 GPBAR1 (0.80) GPBAR1NR1H4CYP2C9HIF1AVDR
SCHEMBL19781078 1.00 GPBAR1 (0.80) GPBAR1NR1H4CYP2C9HIF1AVDR
SCHEMBL25947987 1.00 GPBAR1 (0.80) GPBAR1NR1H4CYP2C9HIF1AVDR
SCHEMBL17641285 1.00 GPBAR1 (0.80) GPBAR1NR1H4CYP2C9HIF1AVDR
SCHEMBL17303273 0.90 GPBAR1 (0.70) GPBAR1NR1H4CYP3A4MEN1KMT2A
SCHEMBL24999603 0.89 GPBAR1 (1.00) GPBAR1NR1H4CYP2C9HIF1AVDR
SCHEMBL22079612 0.89 GPBAR1 (1.00) GPBAR1NR1H4CYP2C9HIF1AVDR
SCHEMBL23424218 0.89 GPBAR1 (1.00) GPBAR1NR1H4CYP2C9HIF1AVDR
SCHEMBL22079590 0.89 GPBAR1 (1.00) GPBAR1NR1H4CYP2C9HIF1AVDR
SCHEMBL21283696 0.89 GPBAR1 (1.00) GPBAR1NR1H4CYP2C9HIF1AVDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180148470-A1 CHOLIC ACID DERIVATIVE, AND PREPARATION METHOD AND MEDICAL USE THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2018-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148470-A1 CHOLIC ACID DERIVATIVE, AND PREPARATION METHOD AND MEDICAL USE THEREOF SLC10A1, NR1H4, SLC10A2 GPBAR1 6/4885NR1H4 2/4885CYP2C9 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback